e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The influence of hyperinflation and systemic inflammation on the 6 minute walking distance in patients with COPD
T. Przybylowski, R. Rubinsztajn, M. Maskey-Warzechowska, M. Paplinska-Goryca, P. Nejman-Gryz, K. Karwat, R. Chazan (Warsaw, Poland)
Source:
Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Session:
Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Session type:
Thematic Poster Session
Number:
2509
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Przybylowski, R. Rubinsztajn, M. Maskey-Warzechowska, M. Paplinska-Goryca, P. Nejman-Gryz, K. Karwat, R. Chazan (Warsaw, Poland). The influence of hyperinflation and systemic inflammation on the 6 minute walking distance in patients with COPD. Eur Respir J 2013; 42: Suppl. 57, 2509
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Cara Williams (Cambridge, United States) - 07.09.2013 13:25
This is an interesting poster. Thanks- could you send me a copy; cara.williams@pfizer.com Best regards Cara
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
The influence of hyperinflation on body composition and cytokine profile in patients with COPD
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Mediation of the effect of airflow obstruction upon six minute Walking distance (6MWD) by cytokine IL6 plasma levels in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Differential response between cycling and walking test following pulmonary rehabilitation in patients with COPD depends on degree of lung hyperinflation
Source: International Congress 2015 – Best abstracts on pulmonary rehabilitation in chronic lung diseases
Year: 2015
Lung hyperinflation in COPD: the impact of pharmacotherapy
Source: Eur Respir Rev 2006; 15: 85-89
Year: 2006
Respiratory work and its components during exercise in interstitial lung disease, COPD and controls
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015
Mechanisms limiting exercise in COPD: new insights
Source: Annual Congress 2005 - Mechanical factors limiting physical exercise in disease
Year: 2005
The influence of smoking on capnometry lung ventilation parameters in chronic obstructive pulmonary disease patients
Source: International Congress 2015 – Molecular pathways of lung injury due to tobacco-related products
Year: 2015
Cardiac chambers and hyperinflation in COPD patients
Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease
Year: 2013
Physiology and consequences of lung hyperinflation in COPD
Source: Eur Respir Rev 2006; 15: 61-67
Year: 2006
Association between dynamic hyperinflation and emphysema distribution in COPD patients
Source: International Congress 2014 – Mechanisms of exercise limitation in disease
Year: 2014
Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
Negative pressure ventilation decreases lung function decline, acute exacerbations and hospitalizations in COPD patients with desaturation during 6 minute walk test
Source: International Congress 2015 – Best abstracts on pulmonary rehabilitation in chronic lung diseases
Year: 2015
Thoracoabdominal asynchrony decreases chest wall volume and affects respiratory kinematics in COPD
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015
Lung hyperinflation, dyspnoe, and exercise tolerance in patients with COPD exacerbation
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
Dynamic hyperinflation contributes to systemic and airway inflammation in patients with COPD
Source: International Congress 2019 – Physiologic assessment of airway diseases
Year: 2019
Prediction of exercise capacity using impulse oscillation system in patients with COPD
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Predictor parameters for exercise intolerance in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Effect of aclidinium bromide on static lung function and hyperinflation in patients with moderate to severe COPD
Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD
Year: 2013
The functional state of the diaphragm in COPD patients with hypoxemia
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Prevalence of small airway dysfunction among GOLD stages in COPD patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept